Consensus dengue virus envelope protein domain III...

Details Consensus dengue virus envelope protein domain III... Consensus dengue virus envelope protein domain III...

2011-07-19

2011-07-19

Parkin, Jeffrey (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C435S005000, C422S430000

Reexamination Certificate

active

07981431

ABSTRACT:
A consensus peptide sequence designed for domain III of the envelope proteins of four serotypes of dengue virus and used in a vaccine against multiple serotypes of dengue virus is disclosed. The vaccine is able to elicit cross-neutralization antibody responses against multiple serotypes of dengue virus.

REFERENCES:
Yauch, L. E., and S. Shresta, 2008, Mouse models of dengue virus infection and disease, Antiviral Res. 80:87-93.
Malavige, G. N., et al., 2004, Dengue viral infections, Postgraduate Medical J., 80:588-601.
Stephenson, J. R., 2005, Understanding dengue pathogenesis: implications for vaccine design, Bull. World Health Org. 83:308-314.
Whiltehead, S. S., et al., 2007, Prospects for a dengue virus vaccine, Nat. Rev. Microbiol. 5:S18-S28.

Affiliated with

Also associated with

Rating

Consensus dengue virus envelope protein domain III... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Consensus dengue virus envelope protein domain III..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Consensus dengue virus envelope protein domain III... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2677983